1. Home
  2. AGMB vs KRO Comparison

AGMB vs KRO Comparison

Compare AGMB & KRO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

AGMB

AgomAb Therapeutics NV American Depositary Shares

N/A

Current Price

$11.86

Market Cap

677.9M

Sector

Health Care

ML Signal

N/A

Logo Kronos Worldwide Inc

KRO

Kronos Worldwide Inc

HOLD

Current Price

$7.39

Market Cap

760.5M

Sector

Industrials

ML Signal

HOLD

Company Overview

Basic Information
Metric
AGMB
KRO
Founded
2017
1916
Country
Belgium
United States
Employees
N/A
N/A
Industry
Biotechnology: Biological Products (No Diagnostic Substances)
Major Chemicals
Sector
Health Care
Industrials
Exchange
Nasdaq
Nasdaq
Market Cap
677.9M
760.5M
IPO Year
N/A
2004

Fundamental Metrics

Financial Performance
Metric
AGMB
KRO
Price
$11.86
$7.39
Analyst Decision
Buy
Strong Sell
Analyst Count
3
2
Target Price
$32.00
$6.00
AVG Volume (30 Days)
137.3K
287.9K
Earning Date
04-23-2026
05-06-2026
Dividend Yield
N/A
2.79%
EPS Growth
N/A
N/A
EPS
N/A
N/A
Revenue
N/A
$1,859,400,000.00
Revenue This Year
N/A
$6.75
Revenue Next Year
$17.86
$8.36
P/E Ratio
N/A
N/A
Revenue Growth
N/A
N/A
52 Week Low
$9.00
$4.08
52 Week High
$17.45
$7.90

Technical Indicators

Market Signals
Indicator
AGMB
KRO
Relative Strength Index (RSI) 54.88 64.15
Support Level $10.30 $6.08
Resistance Level $12.21 N/A
Average True Range (ATR) 0.84 0.36
MACD 0.21 0.07
Stochastic Oscillator 68.15 71.35

Price Performance

Historical Comparison
AGMB
KRO

About AGMB AgomAb Therapeutics NV American Depositary Shares

AgomAb Therapeutics NV is a clinical-stage biopharmaceutical company focused on developing novel disease-modifying therapies for immunology and inflammatory diseases, with an initial focus on chronic fibrotic indications with high unmet medical need. Its product candidates are designed to target established pathways and utilize validated modalities, with a focus on addressing limitations associated with prior treatment approaches. The company's pipeline includes small molecule and antibody product candidates aimed at targets associated with fibrotic diseases. Key candidates include Ontunisertib (AGMB-129) and AGMB-447.

About KRO Kronos Worldwide Inc

Kronos Worldwide Inc manufactures and sells titanium dioxide pigments. Titanium dioxide is a white inorganic pigment used in various products. The majority of Kronos' sales come from titanium dioxide used for coatings on automobiles, aircraft, machines, appliances, traffic paint, and in both commercial and residential interiors and exteriors. The second product category is titanium dioxide used for plastics such as packaging materials and food packaging, houseware, appliances, toys, and computer cases. The maximum of revenue comes from the United States.

Share on Social Networks: